(Q42468905)

1 November 2017

Identification of budesonide and prednisone as substrates of the intestinal drug efflux pump P-glycoprotein (English)

1 reference

1 November 2017

Karin Dilger

1

1 reference

PubMed ID

15472518

1 November 2017

Matthias Schwab

series ordinal

2

1 reference

PubMed ID

15472518

1 November 2017

Martin F Fromm

series ordinal

3

1 reference

1 November 2017

1 September 2004

1 reference

Inflammatory Bowel Diseases

1 November 2017

1 reference

1 November 2017

10

1 reference

1 November 2017

5

1 reference

1 November 2017

578-583

1 reference

Inflammatory Bowel Disease

1 November 2017

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

Genetic polymorphisms of the human MDR1 drug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

Role of P-glycoprotein in pharmacokinetics: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

P-glycoprotein-170 inhibition significantly reduces cortisol and ciclosporin efflux from human intestinal epithelial cells and T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

Pharmacokinetic considerations in the treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

Importance of P-glycoprotein for drug disposition in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

P-glycoprotein: from genomics to mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

Transport and local metabolism of budesonide and fluticasone propionate in a human bronchial epithelial cell line (Calu-3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

Secretory transport of methylprednisolone possibly mediated by P-glycoprotein in Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

Oral Budesonide in the Management of Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

Frequency of glucocorticoid resistance and dependency in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

Glucocorticoid resistance in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

MDR1 Ala893 polymorphism is associated with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

Expression of a multidrug-resistance gene in human tumors and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00012

10.1097/00054725-200409000-00012

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference

PubMed ID

15472518